Renalytix (Reg S) (RENX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 5.90p
   
  • Change Today:
      0.000p
  • 52 Week High: 12.50
  • 52 Week Low: 5.62
  • Currency: UK Pounds
  • Shares Issued: 437.02m
  • Volume: 410,060
  • Market Cap: £25.78m
  • RiskGrade: 348
  • Beta: 0.46

Latest Deals

Traded Action Notifier PriceAmountValue
26-Sep-25 Placing Robert (Rob) Graham Naylor 9.50p 105,263 £9,999.98
26-Sep-25 Placing Catherine Coste 9.50p 105,263 £9,999.98
26-Sep-25 Placing Christopher H B Mills 9.50p 2,500,000 £237,500.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
26-Sep-25 Placing Christopher H B Mills 9.50p 2,500,000 £237,500.00
26-Sep-25 Placing Catherine Coste 9.50p 105,263 £9,999.98
26-Sep-25 Placing Robert (Rob) Graham Naylor 9.50p 105,263 £9,999.98

Director Shareholdings

Notifier Holding Value*
Christopher H B Mills 17,061,345 £1,006,619
James Renwick McCullough 3,242,096 £191,284
Robert (Rob) Graham Naylor 693,318 £40,906
Fergus Fleming 569,481 £33,599
Catherine Coste 385,129 £22,723

Major Shareholders

Notifier** Holding Value*
Heights Capital Management, Inc. 43,151,533 £2,545,940
CVI Holdings, LLC 43,151,533 £2,545,940
Pentwater Capital Management LP 34,049,049 £2,008,894
Ruffer LLP 32,800,000 £1,935,200
UBS Group AG 32,565,952 £1,921,391
Jefferson River Capital LLC 30,755,501 £1,814,575
Unicorn Asset Management Limited 25,797,882 £1,522,075
Harwood Capital LLP 17,061,345 £1,006,619
Harwood Capital LLP 14,609,946 £861,987
ABRDN World Healthcare Fund 14,546,533 £858,245
Vaal Investment Partners 13,827,903 £815,846
Polar Capital, LLP 13,196,197 £778,576
Icahn School of Medicine at Mount Sinai 10,750,926 £634,305
Mount Sinai 8,018,986 £473,120
Gilder Gagnon Howe and Co LLC 6,042,634 £356,515
Forest Nominees Limited 4,001,187 £236,070
Lombard Odier & Co Ltd 2,952,334 £174,188
Amati Global Investors 2,455,247 £144,860
Fidelity Investment International 2,173,851 £128,257

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 5.90p
Change Today 0.000p
% Change 0.00 %
52 Week High 12.50
52 Week Low 5.62
Volume 410,060
Shares Issued 437.02m
Market Cap £25.78m
Beta 0.46
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for 05-Jan-2026

Time Volume / Share Price
15:10 90,000 @ 5.84p
15:10 78,000 @ 5.80p
15:05 25,000 @ 5.84p
14:35 15,000 @ 5.80p
14:32 15,000 @ 5.80p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page